Exhibit 99.2
CONSENT OF CASSEL SALPETER & CO., LLC
Seneca Biopharma, Inc.
20271 Goldenrod Lane
Germantown, MD 20876
Attention: Transaction Committee of the Board of Directors
| RE: | Proxy Statement / Prospectus of Seneca Biopharma, Inc. (“Seneca”) and Information Statement of Leading BioSciences, Inc., which form part of the Registration Statement on Form S-4 of Seneca (the “Registration Statement”). |
Members of the Transaction Committee of the Board of Directors:
We hereby consent to the inclusion of our opinion letter, dated December 16, 2020, to the Transaction Committee of the Board of Directors of Seneca as Annex B to the Proxy Statement/Prospectus/Information Statement included in the Registration Statement filed with the Securities and Exchange Commission today and the references to our firm and our opinion, including the quotation or summarization of such opinion, in such Registration Statement, under the headings “THE MERGER – Background of the Merger,” “THE MERGER – Seneca Reasons for the Merger” and “THE MERGER – Opinion of the Financial Advisor to the Seneca Transaction Committee.” The foregoing consent applies only to the Registration Statement being filed with the Securities and Exchange Commission today and not to any amendments or supplements to the Registration Statement, and our opinion is not to be filed with, included in or referred to in whole or in part in any other registration statement (including any amendments to the above-mentioned Registration Statement), proxy statement or any other document, except in accordance with our prior written consent.
In giving our consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we admit that we are experts with respect to any part of such Registration Statement within the meaning of the term “experts” as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder.
| | |
| | Dated: December 23, 2020 Cassel Salpeter & Co., LLC /s/ Cassel Salpeter & Co., LLC |
| | |
| | |
